Clinical trials
Phase 2 Immune System Diseases trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 4 |
| Unknown status | 3 |
| Active, not recruiting | 1 |
| Completed | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 2 |
| Beeline Medicines Corporation | 1 |
| Eli Lilly and Company | 1 |
| Fudan University | 1 |
| Institute of Hematology & Blood Diseases Hospital, China | 1 |
| Novartis Pharmaceuticals | 1 |
| Pfizer | 1 |
| Sun Yat-sen University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immune System Diseases | 9 |
| Autoimmune Diseases | 5 |
| Connective Tissue Diseases | 3 |
| Arthritis | 2 |
| Dermatitis | 2 |
| Dermatitis, Atopic | 2 |
| Eczema | 2 |
| Hematologic Diseases | 2 |
| Immunoproliferative Disorders | 2 |
| Joint Diseases | 2 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.